Second quarter sales growth of 90%, gross
margin growth of 105%, and positive operating profit
EDMONTON, AB, Aug. 11,
2022 /CNW/ - Nova Cannabis Inc. (the "Company"
or "Nova") (TSX: NOVC) today released its unaudited
condensed interim consolidated financial statements (the
"interim financial statements") and management's discussion
and analysis ("MD&A") for the three months ended
June 30, 2022. All financial
information in this press release is reported in millions of
Canadian dollars and represents results from continuing operations,
unless otherwise indicated.

"The performance of our Value Buds stores continues to outpace
the growth of the industry as we reported record sales for the
second quarter of 2022, underpinned by equally strong sales and
gross margin growth that is driving greater operating leverage to
the bottom line," said Marcie
Kiziak, CEO of Nova. "Delivering superior value to cannabis
consumers will become increasingly important in the current
economic environment, and Value Buds is purpose built for this. We
will stay the course by being disciplined in how we expand our
footprint, remaining customer focused and choosing the best real
estate for our strategy, whether through acquiring stores or
building our own."
FINANCIAL AND OPERATING
HIGHLIGHTS
- Record sales of $56.3 million, a
90% increase from the second quarter of 2021, and a 13% increase
from the first quarter of 2022.
- Gross margin of $10.6 million, or
19% of sales, a 105% increase from the second quarter of 2021 and
consistent with gross margin of 19% of sales for the first quarter
of 2021.
- Nova now has 82 stores currently open, an increase of three
stores since March 31, 2022.
- Positive operating profit before depreciation, impairment, and
other costs of $2.1 million compared
to a loss of $2.5 million for the
second quarter of 2021.
- Increased revolving credit facility from a maximum of
$10 million to a maximum of
$15 million.
- Cash of $6.2 million as at
June 30, 2022.
- On July 22, 2022, announced the
launch of an at-the-market equity offering program (the "ATM
Program") which will allow the Company to issue up to
$20 million of common shares from
treasury to the public at the discretion of the Company and subject
to market conditions and regulatory requirements
SECOND QUARTER 2022 FINANCIAL
RESULTS
Sales
Sales increased 90% compared to the second quarter of 2021, to
$56.3 million from $29.7 million. The increase is primarily due to
the twenty-nine (29) retail cannabis stores that were opened since
March 31, 2021, and increased sales
from stores that were re-branded to the Value Buds discount banner
from "Nova Cannabis," "YSS," and "Sweet Tree" at various times
throughout 2021.
Gross margin
Gross margin for the period was $10.6
million, up $5.4 million or
105.0%, from $5.2 million for the
same period in the prior year. The gross margin as a percent
of sales was 18.8% for the period (Q2 2021 – 17.4%). During
the comparative period for 2021, the stores were operated under the
Nova Cannabis, YSS and Sweet Tree banners with a different
operating, pricing and margin strategy than in the second quarter
of 2022 when sales came primarily from the stores converted to the
Value Buds discount banner. During the current period, the Company
revised prices at certain retail locations where the competitive
response has waned which contributed to the increase in gross
margin percentage.
Operating profit before depreciation,
impairment and other costs
Operating profit excluding depreciation, impairment and other
costs for the three months ended June 30,
2022 was $2.1 million (Q2 2021
– $2.5 million loss). The increased
operating profit excluding depreciation, impairment and other costs
is primarily a result of the increase in sales and gross margin,
partially offset by an increase in selling and distribution
expenses, and a decrease in administrative expenses, for the three
months ended June 30, 2022.
Administrative expenses in the comparative period included
$0.5 million in share-based payment
expense, $0.2 million in severance
expense, and $0.3 million of legal
and professional fees in transitionary costs incurred after the
reverse takeover transaction of YSS Corp. Selling and distribution
expenses in the current period increased by $2.0 million to $7.0
million in the current period from operating a larger number
of stores, however, the selling and distribution expenses as
a percentage of sales decreased from 16.9% to 12.7% due to
increased sales and cost efficiencies in the current period.
Net loss and comprehensive loss
For the three months ended June 30,
2022, the Company recorded a net loss of $1.4 million (Q2 2021 – $7.0 million net loss). The reduction is
primarily a result of the increase in sales and gross margin for
the three months ended June 30,
2022. Income taxes have not been recorded in either period as
the Company incurred taxable losses for the current year to which
deferred tax assets have not been recognized because it is not
probable that sufficient taxable profits will be available against
which the Company may use the benefits. Impairment of $0.9 million was recorded in the prior period for
two (2) stores assumed as part of the reverse takeover transaction
of YSS Corp. which the Company elected to close due to proximity to
existing retail stores.
LIQUIDITY AND CAPITAL
RESOURCES
Summary of Consolidated Cash Flows
|
Three months
ended
|
Six months
ended
|
Cash provided by
(used in)
|
June
30,
|
June
30,
|
(expressed in
thousands)
|
2022
(unaudited)
|
2021
(unaudited)
|
2022
(unaudited)
|
2021
(unaudited)
|
Operating
activities
|
21
|
(6,009)
|
(5,892)
|
(8,539)
|
Investing
activities
|
(2,116)
|
(2,015)
|
(4,975)
|
(2,515)
|
Financing
activities
|
3,398
|
(4,835)
|
6,560
|
34,524
|
Net (decrease)
increase in cash
|
1,303
|
(12,859)
|
(4,307)
|
23,470
|
Revolving Credit Facility
Nova has an uncommitted revolving credit facility with Sundial
in an aggregate principal amount not to exceed $15 million (the "Credit Facility").
As at August 11, 2022,
$8.7 million in principal and accrued
interest is outstanding on the Credit Facility.
STRATEGIC OUTLOOK
Nova is very well positioned to capitalize on the growth that's
in the market while continuing to take market share. The Company
will remain disciplined in how it operates to drive margin
expansion and deliver greater operating leverage.
- The Company is partnering with SNDL Inc. (formerly known as
Sundial Growers Inc.) for Value Buds' private label strategy, which
is expected to launch before the end of 2022. Nova believes that
establishing a high-performing private label will boost loyalty and
drive more traffic to its stores.
- Nova remains on track with our target to add 10 more stores in
Alberta and Ontario in the remainder of 2022 and early
2023.
CONFERENCE CALL
Nova will host a conference call and webcast at 10:30 a.m. EDT (8:30 a.m.
MDT) on Friday, August 12,
2022.
Call Access
Canada: 1-800-319-4610
International: +1-604-638-5340
Webcast Access
To access the live webcast of the call, please visit the
following link:
https://services.choruscall.ca/links/novacannabis2022q2.html
Replay
The webcast archive will be available for three months via the
link provided above.
A telephone replay will be available for one month. To access the
replay dial:
Canada/USA Toll Free: 1-800-319-6413 or International
Toll: +1-604-638-9010
When prompted, enter Replay Access Code: 9297#
For further information, refer to the Company's interim
financial statements and MD&A for the three and six months
ended June 30, 2022, which are
available from the Company's profile on SEDAR, at www.sedar.com, or
on the Company's website at www.novacannabis.ca.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements or
information (collectively "forward-looking statements")
within the meaning of applicable securities legislation.
Forward-looking statements are typically identified by words such
as "continue", "anticipate", "will", "should", "plan", "intention",
and similar words suggesting future events or future performance.
All statements and information other than statements of historical
fact contained in this news release are forward-looking statements.
In particular, this news release contains forward-looking
statements pertaining to: the Company's expectations regarding its
growth and business strategies; the launch of the ATM Program and
the issuance of common shares thereunder; Nova's private label
strategy; and Alberta and
Ontario expansion.
With respect to forward-looking statements contained in this
news release, the Company has made assumptions regarding, among
other things: the Company's ability to identify locations for,
construct and open new stores and the costs related thereto; the
availability of hardware and equipment for those stores; government
regulation and applicable laws will not change in a manner adverse
to the Company; receipt of necessary regulatory approvals to open
new stores; the Company's ability to obtain leases for new sites
and attract the necessary personnel to operate new stores; demand
for the products the Company sells; other factors that will drive
sales growth in the Value Buds banner, including Nova's private
label strategy; availability of acquisition opportunities;
sustainability of competitors' businesses and competition in the
retail cannabis industry, including from the illicit cannabis
market; consumer demands; and factors that influence consumer
behavior.
Although the Company believes that the expectations reflected in
the forward-looking statements, and the assumptions on which such
forward-looking statements are made, are reasonable, especially
given the unprecedented uncertainty of the full extent and impact
of COVID-19, there can be no assurance that such expectations and
assumptions will prove to be correct. Readers should not place
undue reliance on forward-looking statements included in this news
release. Forward-looking statements are not guarantees of future
performance and involve a number of risks and uncertainties that
may cause actual performance and financial results to differ
materially from any estimates, forecasts or projections. These
risks and uncertainties include, among other things, the duration
and severity of the COVID-19 pandemic on the business, operations
and financial condition of the Company; the risk that Nova will be
unable to execute its strategic plan and growth strategy, as
planned without significant adverse impacts from various factors
beyond its control; business decisions and strategies of Sundial,
Nova's indirect majority shareholder; dependence on suppliers;
potential delays or changes in plans with respect to capital
expenditures and the availability of capital on acceptable terms;
risks inherent in the retail cannabis industry; competition for,
among other things, customers, supply, capital and skilled
personnel; changes in labour costs and markets; incorrect
assessments of the value of acquisitions; general economic and
political conditions in Canada
(including Alberta, Ontario and Saskatchewan), and globally; industry
conditions, including changes in government regulations;
fluctuations in foreign exchange or interest rates; unanticipated
operating events; failure to obtain regulatory and third‐party
consents and approvals when required; changes in tax and other laws
that affect Nova and its shareholders; the potential failure of
counterparties to honour their contractual obligations; stock
market volatility; and the other factors described in the Company's
public filings available at www.sedar.com. Readers are cautioned
that this list of risk factors should not be construed as
exhaustive.
The forward-looking statements contained in this news release
are made as of the date hereof. Except as expressly required by
applicable securities legislation, Nova does not undertake any
obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise. The forward-looking statements contained in this news
release are expressly qualified by this cautionary statement.
SOURCE Nova Cannabis Inc.